News & Press Releases
Filter by:
Mintz Earns Firm and Individual Recognition in 2026 IP Stars and Top Women in IP Rankings
August 03, 2026
Several attorneys in Mintz’s Intellectual Property Practice have been recognized in the 2026 edition of IP Stars, published by Managing IP. In addition to individual attorney recognitions, Mintz was recognized in the United States rankings for ITC Litigation, Life Sciences IP, Patent Disputes, PTAB Litigation, and Patent Prosecution.
Mintz advised the placement agents in connection with LB Pharmaceuticals’ $150 Million private placement of common stock and pre-funded warrants.
Mintz Advises Synlogic on Merger with Caldera Therapeutics and $278 Million Private Placement Financing
July 30, 2026
Mintz advised Synlogic, Inc. in its definitive merger agreement with Caldera Therapeutics, Inc. in an all-stock transaction pursuant to which both companies will become wholly owned subsidiaries of a newly formed company that will operate as Caldera Therapeutics, Inc. The transaction is supported by an upsized $278 million concurrent private placement financing from a syndicate of new and existing investors and is expected to close concurrently with the completion of the merger.
Mintz Appoints John Koss to Drive the Firm's AI-Powered Future as Firm’s First Chief Innovation and AI Officer
July 30, 2026
Mintz has elevated John Koss to serve as the firm's first Chief Innovation & AI Officer, reinforcing Mintz's commitment to responsible AI adoption, practical innovation, and the future of technology-enabled legal services. In this newly created role, he will continue to lead Mintz's E-Data Consulting Group and Knowledge Management and Innovation team while overseeing the firm's innovation strategy, AI investments, and technology initiatives.
Mintz advised the placement agents in connection with the $39 Million private placement that is expected to close in connection with the completion of the merger transaction between Scancell Holdings plc and Neuphoria Therapeutics Inc. The private placement is part of up to $89 million of financing expected to be raised by Scancell in connection with the merger transaction through a combination of equity and debt.
Mintz Expands Venture Capital & Emerging Companies Platform in San Francisco with Addition of Michael Torosian
July 21, 2026
SAN FRANCISCO — Mintz welcomes Michael Torosian as a Corporate partner in its Venture Capital & Emerging Companies Practice. Based in the firm’s San Francisco office, Michael expands Mintz's capabilities serving founders, companies, and investors throughout the innovation economy.
